ロード中...
Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma
BACKGROUND: The need for new therapies for cholangiocarcinoma is highlighted by their poor prognosis and refractoriness to chemotherapy. Increased production of Interleukin-6 promotes cholangiocarcinoma growth and contributes to chemoresistance by activating cell survival mechanisms. We sought to id...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002961/ https://ncbi.nlm.nih.gov/pubmed/21179572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0015195 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|